November 18, 2026
Health news, explained with evidence
LIVE

Genetic Study on Rare Anemia Type Identifies New Variants and mRNA Defects in Indian Cohort

🏃 Fitness 2 min read 👁 3

A recent clinical and molecular analysis of 29 patients with congenital dyserythropoietic anaemia type II has identified thirteen SEC23B gene variants, expanding the recognized mutational spectrum of the rare inherited disorder.

🏃Fitness

Key points

  • Identified 13 SEC23B gene variants in 29 CDA II patients
  • Detected two novel variants alongside decreased mRNA expression levels
  • Patients presented with moderate to severe anemia and iron overload

Researchers publishing in Nature Health Sciences have detailed the clinical, hematological, and molecular characteristics of congenital dyserythropoietic anaemia type II (CDA II) within an Indian cohort of 29 patients. The autosomal recessive condition is typically caused by mutations in the SEC23B gene, leading to inefficient red blood cell production, hemolysis, and complications such as iron overload and gallstones. Affected individuals evaluated in the project exhibited symptoms including pallor, yellowing of the skin, and spleen enlargement, accompanied by moderate to severe anemia.

Laboratory evaluations revealed hypochromic microcytic anemia alongside distinct bone marrow abnormalities, such as binucleated erythroblasts and elevated serum ferritin levels. Utilizing targeted next-generation sequencing, the team identified 13 distinct SEC23B variants, highlighted by a recurrent homozygous mutation alongside two previously undocumented variants—a nonsense mutation and a splice-site mutation. Furthermore, quantitative real-time polymerase chain reaction testing demonstrated diminished SEC23B messenger RNA levels across all participants, noting more pronounced reductions in compound heterozygous individuals. Management strategies for the cohort ranged from blood transfusions and splenectomy to hematopoietic stem cell transplantation.

While this investigation broadens the understanding of genetic variations linked to CDA II, the findings stem from a relatively small observational cohort of 29 patients. Medical professionals note that expanding genetic databases helps refine diagnostic precision for rare inherited blood conditions, though patients should consult qualified hematologists regarding individual care plans.

What to know: Researchers identified 13 SEC23B variants and reduced mRNA expression in a cohort of 29 patients with congenital dyserythropoietic anaemia type II. Always consult a physician for personal medical decisions and specialized hematologic care.

Source Nature Health Sciences — nature.com/articles/s41598-026-79723-4 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.